ONCOCYTE CORP

NASDAQ: OCX (OncoCyte Corporation)

Last update: 8 hours ago

0.218

-0.02 (-7.67%)

Previous Close 0.236
Open 0.235
Volume 902,396
Avg. Volume (3M) 534,972
Market Cap 35,930,976
Price / Sales 12.24
Price / Book 7.56
52 Weeks Range
0.200 (-8%) — 1.35 (516%)
Earnings Date 8 Aug 2023 - 14 Aug 2023
Operating Margin (TTM) -273.01%
Diluted EPS (TTM) -3.79
Quarterly Revenue Growth (YOY) 1,114.80%
Total Debt/Equity (MRQ) 34.04%
Current Ratio (MRQ) 3.74
Operating Cash Flow (TTM) -22.74 M
Levered Free Cash Flow (TTM) -15.27 M
Return on Assets (TTM) -22.17%
Return on Equity (TTM) -428.96%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Mixed Bullish
Diagnostics & Research (Global) Mixed Bullish
Stock OncoCyte Corporation Mixed Mixed

AIStockmoo Score

0.2
Analyst Consensus NA
Insider Activity NA
Price Volatility 3.0
Technical Moving Averages -2.5
Technical Oscillators 0.0
Average 0.17

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
OCX 36 M - - 7.56
FONR 120 M - 19.10 0.670
PMD 28 M - - -
CNTG 23 M - - -
MYNZ 9 M - - 2.97
CHEK 9 M - - 0.250

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Small Value
% Held by Insiders 22.03%
% Held by Institutions 56.30%

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria